Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

More OTC-related cases in ERs

This article was originally published in The Tan Sheet

Executive Summary

U.S. emergency room visits involving abuse of dextromethorphan-containing cough/cold medicines contributed to a 26% increase from 2004 to 2005 in the number of cases related to abuse of OTC and prescription medicines, results of a survey done for the Substance Abuse and Mental Health Services Administration show. In the 1Drug Abuse Warning Network survey's category of ER cases involving respiratory agents, some of which contain DXM, upper respiratory agent cases increased from 9,433 to 12,613 expectorant cases grew from 1,258 to 2,127 and cases involving other upper respiratory products increased from 1,979 to 4,004, although decongestant-related cases were down, 1,468 to 1,287. The latest Monitoring the Future survey as well as results of a study published in December 2006 also point to growing abuse of DXM products, particularly by young people (2"The Tan Sheet," Dec. 11, 2006, p. 10, and 3"The Tan Sheet," Jan. 1, 2007, p. 8). NSAIDs-related cases increased from 22,959 to 26,050; Ibuprofen-related cases and naproxen cases were both up, according to DAWN. Additionally, acetaminophen-related cases were up to 39,494 from 36,818...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS100313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel